Keshavarz et al. (2024) investigated the anti‐EGFR activity of thymol‐based nanoliposome in SW84 and SW111 CRC cell lines and found that thymol‐nanoliposome (IC50 14.2 and 6.4 μg/mL) inhibited SW48 and SW1116 cells growth respectively. Here, EGFR is linked to colorectal carcinoma.